What is the market doing?
What the tape says about HIMS
Hims & Hers Health, Inc. is −38% over the past year while the S&P 500 is +20%: 58 points behind the market. Through the fall, its own insiders bought $1.2M more stock than they sold.
−38%
1-year return · S&P 500 +20%
- vs 200-day average
- −2.1%
vs 200-day average · below trend, but not far
- RSI (14)
- 49
RSI (14) · neutral
- Below its 52-week high
- 55%
Below its 52-week high
Details›
- Last close2026-09-08
- $28.18
- 1 monthS&P 500 −0.30%
- −5.0%
- 1 yearS&P 500 +20%
- −38%
- 5 yearsS&P 500 +85%
- +272%
- vs 50-day average$30.94
- −8.9%
- 52-week high
- $62.76
- 52-week low
- $14.52
- Annualised volatility
- 103%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $1.2M
| Year | Return |
|---|---|
| 2026 (year to date) | −13% |
| 2025 | +34% |
| 2024 | +172% |
| 2023 | +39% |
| 2022 | −2.1% |
| 2021 | −55% |
| 2020 | +47% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 4 of 7 | +9.9% |
| Feb | 7 | 4 of 7 | +6.6% |
| Mar | 7 | 3 of 7 | +1.1% |
| Apr | 7 | 3 of 7 | +1.9% |
| May | 7 | 3 of 7 | +16% |
| Jun | 7 | 5 of 7 | +1.8% |
| Jul | 7 | 4 of 7 | +4.8% |
| Aug | 7 | 3 of 7 | −12% |
| Sep | 7 | 3 of 7 | +6.2% |
| Oct | 7 | 2 of 7 | −7.3% |
| Nov | 7 | 5 of 7 | +19% |
| Dec | 7 | 3 of 7 | −0.15% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #21 of 29 by Smart Score